UK-based healthcare company, Haemoband Surgical has signed an exclusive distribution agreement with Saudi Arabia’s leading healthcare supplier, Almarfa Medical in order to supply best-in-class haemorrhoid treatment devices to key healthcare providers for two years.
Almarfa’s key clients include many of the large healthcare providers in the Kingdom, which support the provision of medical treatment to a population of 35 million people.
Over the two years, Haemoband surgical will supply its world-class Haemoband Plus device, the first multi-action, pre-loaded disposable ligator for the treatment of haemorrhoids, to major healthcare providers across the Kingdom.
Mr. Jamal Abahussein, Chairman, Almarfa Medical said that, “Our partnership with Haemoband Surgical is demonstrative of Almarfa Medical’s commitment to importing best-in-class medical technology, which will support the treatment of patients across the Saudi healthcare sector. Such strategic partnerships underpin the Kingdom’s vision and commitment to develop a best-in-class healthcare sector.”
“With Haemoband’s revolutionary technology, and our world-class distribution team, we will redefine colorecta technology and bring the benefits of minimally invasive surgery to patients across the Kingdom,” Mr. Abahussein added.
As per the statement, the provision of this new technology will empower surgeons with the capabilities to optimize medical diagnosis and surgery outcomes for patients.
Mr. Michael McMullan, General Manager at Haemoband Surgical stated that, “Almarfa Medical is a natural partner for Haemoband as we expand our presence in the Middle East. As we continue to accelerate our expansion, with the support of Invest NI, we now have a major opportunity to supply our products and technology to the high-growth Saudi Arabian market, alongside bolstering the ties between our countries in one of the most important aspects of life, healthcare.”
